0001209191-18-063956.txt : 20181221
0001209191-18-063956.hdr.sgml : 20181221
20181221171113
ACCESSION NUMBER: 0001209191-18-063956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181219
FILED AS OF DATE: 20181221
DATE AS OF CHANGE: 20181221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZACCARDELLI DAVID
CENTRAL INDEX KEY: 0001627642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38135
FILM NUMBER: 181250441
MAIL ADDRESS:
STREET 1: 300 TRI STATE INTERNATIONAL
STREET 2: SUITE 272
CITY: LINCOLNSHIRE
STATE: IL
ZIP: 60069
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dova Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001685071
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813858961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 240 LEIGH FARM ROAD
CITY: DURHAM
STATE: NC
ZIP: 27707
BUSINESS PHONE: 919-806-4487
MAIL ADDRESS:
STREET 1: 240 LEIGH FARM ROAD
CITY: DURHAM
STATE: NC
ZIP: 27707
FORMER COMPANY:
FORMER CONFORMED NAME: Dova Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20160919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-12-19
0
0001685071
Dova Pharmaceuticals Inc.
DOVA
0001627642
ZACCARDELLI DAVID
C/O DOVA PHARMACEUTICALS, INC.
240 LEIGH FARM ROAD, SUITE 245
DURHAM
NC
27707
0
1
0
0
President & CEO
Common Stock
2018-12-19
4
A
0
82372
A
82372
D
Common Stock
2018-12-20
4
P
0
10000
6.07
A
92372
D
Employee Stock Option (right to buy)
6.07
2018-12-19
4
A
0
1000000
0.00
A
2028-12-18
Common Stock
1000000
1000000
D
Represents a restricted stock unit ("RSU") award that vests 50% on June 28, 2019 and 25% on each of September 30, 2019 and December 31, 2019.
Each RSU represents a contingent right to receive one share of Issuer common stock.
25% of the total shares subject to the option shall vest on December 17, 2019, and 1/48th of total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service with the Issuer as of each such date.
/s/ Mark Ballantyne, Attorney-in-Fact
2018-12-21